During the past decade, The Jikei University Hospital conducted 54 clinical trials. In the 10-year time frame, 54 clinical trials started and 40 clinical trials were completed, i.e. on average, 74.1% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 29 clinical trials were completed. i.e. 138.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Jikei University Hospital" #1 sponsor was "Shire" with 7 trials, followed by "Pfizer" with 6 trials sponsored, "Takeda" with 5 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored and "Janssen Research & Development, LLC" with 4 trials sponsored. Other sponsors include 57 different institutions and companies that sponsored additional 48 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Jikei University Hospital" #1 collaborator was "Gilead Sciences" with 3 trials as a collaborator, "Ministry of Health, Labour and Welfare, Japan" with 3 trials as a collaborator, "National Cancer Institute (NCI)" with 3 trials as a collaborator, "Japan Lung Cancer Society" with 2 trials as a collaborator and "NRG Oncology" with 2 trials as a collaborator. Other collaborators include 17 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "The Jikei University Hospital" are "Crohn's Disease" (10 trials), "Ulcerative Colitis" (9 trials), "Ovarian Cancer" (5 trials), "Fallopian Tube Cancer" (4 trials) and "Prostate Cancer" (4 trials). Many other conditions were trialed in "The Jikei University Hospital" in a lesser frequency.

Most popular intervention types in "The Jikei University Hospital" are "Drug" (64 trials), "Device" (13 trials), "Other" (13 trials), "Biological" (9 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (19 trials), "Paclitaxel" (5 trials), "Carboplatin" (4 trials), "Filgotinib" (4 trials) and "Guselkumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "The Jikei University Hospital" are 68 trials for "All" genders, 14 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "The Jikei University Hospital". undefined are not yet recruiting, 10 are recruiting, 18 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 51 completed trials in The Jikei University Hospital, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in The Jikei University Hospital, 2 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 50 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 12 trials that are defined as “Not Applicable".